Market Tracker

11/17 5:15pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

18.28
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
9.68
Today|||52-Week Range
19.37
+85.02%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close18.28
Today’s open18.41
Day’s range18.17 - 18.62
Volume704,650
Average volume (3 months)1,220,913
Market cap$2.6B
Dividend yield--
Data as of 4:00pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)-224.00%
Earnings growth (this year)+119.32%
Earnings growth (next 5 years)+9.10%
Revenue growth (last year)+8.61%
P/E ratioNM
Price/Sales8.62
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc0.000.00%
BPMCBlueprint Medicines ...0.000.00%
XLRNAcceleron Pharma Inc0.000.00%
XONIntrexon Corp0.000.00%
Data as of 4:02pm ET, 11/17/2017

Financials

Next reporting dateFebruary 26, 2018
EPS forecast (this quarter)$0.59
Annual revenue (last year)$146.7M
Annual profit (last year)-$103.0M
Net profit margin-70.23%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts